The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency Fig 1. Summary of key NACT for advanced EOC recommendations. C, conditional; ECOG, Eastern Cooperative ...

Among patients with platinum-sensitive peritoneal recurrent epithelial ovarian cancer undergoing secondary cytoreductive surgery (SCS), the addition of hyperthermic intraperitoneal chemotherapy (HIPEC ...

How a radical surgical approach saved the life of a neonatal nurse practitioner with a rare abdominal cancer - but meant ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

MUSTAFA RAOOF ONCOLOGY Assistant Professor, Division of Surgical Oncology, Department of Surgery; Assistant Professor, Department of Cancer Genetics and ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...